Trending News

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
Posted On Wednesday, February 26, 2025
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update
Posted On Wednesday, February 26, 2025
Aquestive Therapeutics to Participate in Two Upcoming Conferences in March
Posted On Wednesday, February 26, 2025
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
Posted On Wednesday, February 26, 2025
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
Posted On Wednesday, February 26, 2025
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis
Posted On Wednesday, February 26, 2025
Benitec Biopharma to Participate in Upcoming Conferences in March
Posted On Wednesday, February 26, 2025
Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy
Posted On Wednesday, February 26, 2025
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
Posted On Wednesday, February 26, 2025
OXB to present at the Leerink Partners Global Healthcare Conference
Posted On Wednesday, February 26, 2025
Tenapanor Approved in China for Hyperphosphatemia
Posted On Wednesday, February 26, 2025
Wugen Announces Appointment of Jim Faulkner, Ph.D., as Chief Technology Officer
Posted On Wednesday, February 26, 2025
Tilray Brands Announces 420 Concert with Multi-Platinum Artist Don Toliver
Posted On Wednesday, February 26, 2025
Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis
Posted On Wednesday, February 26, 2025
AscellaHealth Supports Rare Disease Patients and Caregivers in Observance of Rare Disease Day, February 28
Posted On Wednesday, February 26, 2025
OMass Therapeutics appoints Birgitte Volck as Non-Executive Director
Posted On Wednesday, February 26, 2025
Jasper Therapeutics to Present at Upcoming March Investor Conferences
Posted On Tuesday, February 25, 2025
Ardelyx to Participate in Upcoming Investor Conferences
Posted On Tuesday, February 25, 2025
ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones
Posted On Tuesday, February 25, 2025
Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia
Posted On Tuesday, February 25, 2025
Bolt Biotherapeutics to Participate in Upcoming March Conferences
Posted On Tuesday, February 25, 2025
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024
Posted On Tuesday, February 25, 2025
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
Posted On Tuesday, February 25, 2025
Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress
Posted On Tuesday, February 25, 2025
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results
Posted On Tuesday, February 25, 2025

Print